These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27416952)

  • 1. Factors contributing to partial remission in type 1 diabetes: analysis based on the insulin dose-adjusted HbA1c in 3657 children and adolescents from Germany and Austria.
    Nagl K; Hermann JM; Plamper M; Schröder C; Dost A; Kordonouri O; Rami-Merhar B; Holl RW
    Pediatr Diabetes; 2017 Sep; 18(6):428-434. PubMed ID: 27416952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial remission in type 1 diabetes and associated factors: Analysis based on the insulin dose-adjusted hemoglobin A1c in children and adolescents from a regional diabetes center, Auckland, New Zealand.
    Chiavaroli V; Derraik JGB; Jalaludin MY; Albert BB; Ramkumar S; Cutfield WS; Hofman PL; Jefferies CA
    Pediatr Diabetes; 2019 Nov; 20(7):892-900. PubMed ID: 31237756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial remission definition: validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish children with new-onset type 1 diabetes.
    Max Andersen ML; Hougaard P; Pörksen S; Nielsen LB; Fredheim S; Svensson J; Thomsen J; Vikre-Jørgensen J; Hertel T; Petersen JS; Hansen L; Mortensen HB
    Pediatr Diabetes; 2014 Nov; 15(7):469-76. PubMed ID: 25287319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial clinical remission in type 1 diabetes: a comparison of the accuracy of total daily dose of insulin of <0.3 units/kg/day to the gold standard insulin-dose adjusted hemoglobin A1c of ≤9 for the detection of partial clinical remission.
    Lundberg RL; Marino KR; Jasrotia A; Maranda LS; Barton BA; Alonso LC; Nwosu BU
    J Pediatr Endocrinol Metab; 2017 Aug; 30(8):823-830. PubMed ID: 28753540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in insulin sensitivity in the partial remission phase of childhood type 1 diabetes; a longitudinal cohort study.
    Mørk FCB; Madsen JOB; Jensen AK; Hall GV; Pilgaard KA; Pociot F; Johannesen J
    Diabet Med; 2022 Feb; 39(2):e14702. PubMed ID: 34564895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial remission in children and adolescents with type 1 diabetes: an analysis based on the insulin dose-adjusted hemoglobin A1c.
    Cimbek EA; Bozkır A; Usta D; Beyhun NE; Ökten A; Karagüzel G
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1311-1317. PubMed ID: 34271601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New definition for the partial remission period in children and adolescents with type 1 diabetes.
    Mortensen HB; Hougaard P; Swift P; Hansen L; Holl RW; Hoey H; Bjoerndalen H; de Beaufort C; Chiarelli F; Danne T; Schoenle EJ; Aman J;
    Diabetes Care; 2009 Aug; 32(8):1384-90. PubMed ID: 19435955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Metabolic Outcomes in Children Diagnosed with Type 1 Diabetes Through Research Screening (Diabetes Autoimmunity Study in the Young [DAISY]) Versus in the Community.
    Chan CL; Taki I; Dong F; Hoffman M; Norris JM; Klingensmith G; Rewers MJ; Steck AK
    Diabetes Technol Ther; 2015 Sep; 17(9):649-56. PubMed ID: 26317880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic ketoacidosis at the onset of type 1 diabetes is associated with future HbA1c levels.
    Fredheim S; Johannesen J; Johansen A; Lyngsøe L; Rida H; Andersen ML; Lauridsen MH; Hertz B; Birkebæk NH; Olsen B; Mortensen HB; Svensson J;
    Diabetologia; 2013 May; 56(5):995-1003. PubMed ID: 23389397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 diabetes during adolescence: International comparison between Germany, Austria, and Sweden.
    Hanberger L; Samuelsson U; Holl RW; Fröhlich-Reiterer E; Åkesson K; Hofer S
    Pediatr Diabetes; 2018 May; 19(3):506-511. PubMed ID: 28940551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study.
    Cengiz E; Cheng P; Ruedy KJ; Kollman C; Tamborlane WV; Klingensmith GJ; Gal RL; Silverstein J; Lee J; Redondo MJ; Beck RW;
    Pediatr Diabetes; 2017 Nov; 18(7):566-573. PubMed ID: 27758023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial Clinical Remission of Type 1 Diabetes: The Need for an Integrated Functional Definition Based on Insulin-Dose Adjusted A1c and Insulin Sensitivity Score.
    Nwosu BU
    Front Endocrinol (Lausanne); 2022; 13():884219. PubMed ID: 35592786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does β-Cell Autoimmunity Play a Role in Cystic Fibrosis-Related Diabetes? Analysis Based on the German/Austrian Diabetes Patienten Verlaufsdokumentation Registry.
    Konrad K; Kapellen T; Lilienthal E; Prinz N; Bauer M; Thon A; Rietschel E; Wiemann D; Holl RW;
    Diabetes Care; 2016 Aug; 39(8):1338-44. PubMed ID: 27271187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry.
    Clements MA; Foster NC; Maahs DM; Schatz DA; Olson BA; Tsalikian E; Lee JM; Burt-Solorzano CM; Tamborlane WV; Chen V; Miller KM; Beck RW;
    Pediatr Diabetes; 2016 Aug; 17(5):327-36. PubMed ID: 26153338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone turnover markers during the remission phase in children and adolescents with type 1 diabetes.
    Madsen JOB; Herskin CW; Zerahn B; Jensen AK; Jørgensen NR; Olsen BS; Svensson J; Pociot F; Johannesen J
    Pediatr Diabetes; 2020 Mar; 21(2):366-376. PubMed ID: 31840392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.
    Pinckney A; Rigby MR; Keyes-Elstein L; Soppe CL; Nepom GT; Ehlers MR
    Clin Ther; 2016 Jun; 38(6):1327-1339. PubMed ID: 27209482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An online tool using clinical factors to estimate the probability of partial clinical remission of adult-onset Type 1 diabetes.
    Januszewski AS; Grzelka-Wozniak A; Flotynska J; Jenkins AJ; Zozulinska-Ziolkiewicz DA; Uruska AA
    J Diabetes Complications; 2024 Sep; 38(9):108828. PubMed ID: 39084177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual and diabetes presentation characteristics associated with partial remission status in children and adults evaluated up to 12 months following diagnosis of type 1 diabetes: An ADDRESS-2 (After Diagnosis Diabetes Research Support System-2) study analysis.
    Humphreys A; Bravis V; Kaur A; Walkey HC; Godsland IF; Misra S; Johnston DG; Oliver NS
    Diabetes Res Clin Pract; 2019 Sep; 155():107789. PubMed ID: 31326456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries.
    Maahs DM; Hermann JM; DuBose SN; Miller KM; Heidtmann B; DiMeglio LA; Rami-Merhar B; Beck RW; Schober E; Tamborlane WV; Kapellen TM; Holl RW; ;
    Diabetologia; 2014 Aug; 57(8):1578-85. PubMed ID: 24893863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proportion of Basal to Total Insulin Dose Is Associated with Metabolic Control, Body Mass Index, and Treatment Modality in Children with Type 1 Diabetes-A Cross-Sectional Study with Data from the International SWEET Registry.
    Rasmussen VF; Vestergaard ET; Schwandt A; Beltrand J; Rami-Merhar B; O'Riordan SMP; Jarosz-Chobot P; Castro-Correia C; Gevers EF; Birkebæk NH
    J Pediatr; 2019 Dec; 215():216-222.e1. PubMed ID: 31345576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.